feed,title,long_url,short_url
Benzinga,ICER's Report Suggests Benefits Of Eli Lilly's Tirzepatide Not Better Than Other Diabetes Drugs,https://benzinga.com/general/biotech/22/02/25667083/icers-report-suggests-benefits-of-eli-lillys-tirzepatide-not-better-than-other-diabetes-drugs,https://bit.ly/3JvEk99
Benzinga,Read How Analysts Reacted To Allegion's Q4 Results,https://benzinga.com/analyst-ratings/analyst-color/22/02/25670825/read-how-analysts-reacted-to-allegions-q4-results,https://bit.ly/3HWRnA8
